









Markets
/
Stocks
/
nasdaq-agl
/

agilon health inc

AGL

0.667USD

-0.030-4.30%

Close 11/07, 16:00（ET）Quotes delayed by 15 min

276.60MMarket Cap

LossP/E TTM



agilon health inc

0.667

-0.030-4.30%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of agilon health inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. The company shows very weak stock market performance, in line with its fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

agilon health inc's Score

Industry at a Glance

Industry Ranking

57 / 78

Overall Ranking

298 / 4614

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 18 analysts

Hold

Current Rating

1.092

Target Price

+56.58%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

agilon health inc Highlights

StrengthsRisks

agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 153.77% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 6.06B.

Overvalued

The company’s latest PE is -0.89, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 389.82M shares, decreasing 10.25% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 24.29M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 3.02.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 5.67, which is lower than the Healthcare Providers & Services industry's average of 7.24. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 1.44B, representing a year-over-year decrease of 1.08%, while its net profit experienced a year-over-year decrease of 6.30%.

Score

Industry at a Glance

Previous score

5.67

Change



Financials

5.36

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.21

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

6.66

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

3.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.11

Key Metrics

Free cash flow

No Data

agilon health inc's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 7.89, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is -0.89, which is 0.00% below the recent high of -0.89 and -14028.87% above the recent low of -126.30.

Score

Industry at a Glance

Previous score

7.89

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 57/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Providers & Services industry's average of 7.56. The average price target for agilon health inc is 1.00, with a high of 2.00 and a low of 0.25.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 18 analysts

Hold

Current Rating

1.092

Target Price

+56.58%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

agilon health inc

AGL

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 4.28, which is lower than the Healthcare Providers & Services industry's average of 7.06. Sideways: Currently, the stock price is trading between the resistance level at 0.97 and the support level at 0.50, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

4.08

Change

0.2

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.035

Sell

RSI(14)

27.427

Sell

STOCH(KDJ)(9,3,3)

8.667

Oversold

ATR(14)

0.076

Low Volatility

CCI(14)

-138.208

Sell

Williams %R

91.923

Oversold

TRIX(12,20)

-1.271

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.730

Sell

MA10

0.797

Sell

MA20

0.878

Sell

MA50

1.025

Sell

MA100

1.405

Sell

MA200

2.463

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-07

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 94.06%, representing a quarter-over-quarter decrease of 12.01%. The largest institutional shareholder is The Vanguard, holding a total of 24.29M shares, representing 5.86% of shares outstanding, with 22.17% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Clayton, Dubilier & Rice, LLC

100.00M

Morgan Stanley Investment Management Inc. (US)

54.17M

+8.05%

Fidelity Management & Research Company LLC

31.20M

+98.56%

The Vanguard Group, Inc.

Star Investors

30.23M

+0.04%

North Peak Capital Management, LLC

21.54M

BlackRock Institutional Trust Company, N.A.

20.91M

-1.74%

Capital World Investors

10.85M

-76.18%

Capital International Investors

9.89M

-55.70%

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 1.80, which is lower than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 0.07. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.